Chinese biotech firm BeiGene seeks to raise $3.5b in STAR Market IPO

Chinese biotech firm BeiGene seeks to raise $3.5b in STAR Market IPO

Photo: Bloomberg

02 December, 2021

Printed by Unregistered user on Sat, 06 Dec 2025 05:50:58 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

HK, Nasdaq-listed Chinese biotech firm BeiGene to raise $2.08b in share sale

BeiGene raises $903m in HK's first secondary listing under new rules

Read more from Greater China

Alibaba to retire Ele.me brand amid instant-retail push

HongShan aims for $2.9b sale of Golden Goose to Permira by Christmas: report